In mice, metformin treatment for 14 weeks significantly prevented high-fat diet induced obesity and the associated inflammatory response through increasing the expression of FGF21 (fibroblast growth factor 21), a key metabolic hormone that improves lipolysis in white adipose tissue to prevent fat accumulation (88). The gene discussed is FGF21; the disease is obesity due to melanocortin 4 receptor deficiency.